Odyssey Therapeutics, Inc. ( ODTX) - Stock Earnings
ODTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
ODTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -41.2 million USD | 959000 USD |
| 2026Q1 | -38.3 million USD | — USD |
| 2026Q2 | -52.8 million USD | — USD |
| 2027Q2 Est. | — | — |
ODTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -125.9 million USD | 1.0 million USD |
| 2024 | -129.3 million USD | 4.5 million USD |
| 2025 | -148.6 million USD | 3.0 million USD |
| 2026 Est. | — | — |
ODTX
Price: $17.17
52 week price:
Earnings Per Share: -3.52 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 995.4 million